source
- ADC biotech Ona Therapeutics raises $86.6M in Series B to move two ADC candidates toward clinicBarcelona-based Ona Therapeutics announced a $86.6 million Series B financing round. The capital will be used to move two antibody‑drug conjugate (ADC) programs into early‑stage clinical testing.…
- Acting FDA Commissioner Kyle Diamantas says he will not seek permanent appointmentActing FDA Commissioner Kyle Diamantas has indicated that he does not intend to remain in the role on a permanent basis. Sources close to the administration say that the search for a new permanent…